ANTHONY GIGLIO: Open Payments
NPI 1134268956 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$668 in 63 payments from 10 companies in 2025. Trend: 2023 $312 · 2024 $332 · 2025 $668
Food & beverage: $668
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 22 | $220 |
| Novo Nordisk Inc | 23 | $138 |
| Sequel Med Tech, LLC | 4 | $65 |
| Abbott Laboratories | 4 | $64 |
| PFIZER INC. | 3 | $49 |
| RGH Enterprises LLC | 1 | $45 |
| Insulet Corporation | 1 | $30 |
| BETA BIONICS, INC. | 3 | $25 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $18 |
| Medtronic, Inc. | 1 | $16 |
Products named: Dexcom G6 Transmitter, Ozempic, TWIIST, FREESTYLE LIBRE, SOMAVERT, Rybelsus, Omnipod, iLet Bionic Pancreas.
Industry payments across MO — which companies pay providers there.
